2006
DOI: 10.1016/j.jcv.2006.04.006
|View full text |Cite
|
Sign up to set email alerts
|

CT appearance of Varicella Zoster lesions in liver and spleen in an immunocompetent patient

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
7
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 9 publications
1
7
0
Order By: Relevance
“…Persistent detection of VZV DNA and lesions in liver and spleen have been described previously. 2,3 The disease is often more severe in adults than in children, with more prominent rash, fever and interstitial pneumonitis. Bleeding abnormalities, including increased capillary fragility, disseminated intravascular coagulation, and thrombocytopenia, may also occur.…”
Section: Introductionmentioning
confidence: 99%
“…Persistent detection of VZV DNA and lesions in liver and spleen have been described previously. 2,3 The disease is often more severe in adults than in children, with more prominent rash, fever and interstitial pneumonitis. Bleeding abnormalities, including increased capillary fragility, disseminated intravascular coagulation, and thrombocytopenia, may also occur.…”
Section: Introductionmentioning
confidence: 99%
“…The patient was immunocompromised and died of multi-organ failure soon after the CT. In the other report [3] an immunocompetent patient responded to aciclovir therapy and a follow-up study showed resolution of the liver lesions. Our report, therefore, is only the second imaging description of VZV hepatitis, which responded to appropriate antiviral therapy.…”
Section: Discussionmentioning
confidence: 85%
“…The blood test results confirmed a lymphopaenia 0. 3 ). Hepatitis virus antibodies (hepatitis B and C) and antibody markers of autoimmune diseases were all negative.…”
mentioning
confidence: 99%
“…8 The average age for disseminated herpes zoster in reported immunocompetent patients is 65.4 years. 7,9,10 The signs and symptoms resolved in three out of five of the patients with oral acyclovir, while the others were given IV dosing. 7,9,10 At the age of 39, our patient is significantly younger than the average reported age of disseminated zoster in immunocompetent patients, indicating that he is not likely to have the age-related decline of VZV-specific T cell immunity that is characteristic of advanced age, and his dissemination occurred after completion of antiviral therapy.…”
Section: Discussionmentioning
confidence: 99%